Literature DB >> 11002394

Adenoviral gene transfer of endothelial nitric oxide synthase (eNOS) to the penis improves age-related erectile dysfunction in the rat.

T J Bivalacqua1, H C Champion, Y S Mehta, A B Abdel-Mageed, S C Sikka, L J Ignarro, P J Kadowitz, W J Hellstrom.   

Abstract

Nitric oxide (NO) is the principal mediator of penile erection. NO is synthesized by a variety of nitric oxide synthases (NOS). It has been demonstrated that a decrease in NOS activity, as observed in aging, is associated with a diminished erectile response. The objective of this study was to determine if adenoviral-mediated gene transfer of eNOS could reverse age-related erectile dysfunction in the rat. Two groups of animals were transfected with adenoviruses: (1) aged rats (60 weeks) with AdRSVbetagal; and (2) aged rats (60 weeks) with AdRSVeNOS. Five days after transfection, these study animals underwent cavernosal nerve stimulation (CNS) to assess erectile function and their responses were compared with young (20 weeks) control rats. Cross-sections of the rat penises transfected with AdRSVeNOS were examined after trichrome staining. Adenoviral transduction efficiency of beta-galactosidase reporter gene was measured by a galacto-light chemiluminescent reporter gene assay in cavernosal tissues of rats administered AdRSVbetagal. The transgene expression of eNOS was examined by RT-PCR in rats transfected with AdRSVbetagal and AdRSVeNOS. eNOS and iNOS protein levels were measured by Western blot analysis, and cGMP levels were assessed in cavernosal tissue by enzyme immunoassay. Adenoviral expression of the beta-galactosidase reporter gene was observed in cavernosal tissue for up to 30 days, with peak expression registered at 5 days after intracavernosal administration of AdRSVbetagal. Cross-sections of the rat penises transfected with the AdRSVeNOS revealed no pathological (morphological or histological) changes. Five days after administration of AdRSVeNOS, eNOS protein, mRNA and cGMP levels in the corpora cavernosa were significantly increased (P<0. 05), while iNOS protein levels remained unchanged (P>0.05). In conclusion, enhanced expression of eNOS employing an adenoviral vector significantly increased the erectile response to cavernosal nerve stimulation in the aged rat, similar to the response observed in younger rats. These data suggest that in vivo adenoviral gene transfer of eNOS can physiologically improve erectile function in the aged rat.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11002394     DOI: 10.1038/sj.ijir.3900556

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  13 in total

Review 1.  Therapy of erectile dysfunction: potential future treatments.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

Review 2.  Mesenchymal stem cell-based gene therapy for erectile dysfunction.

Authors:  J H Kim; H J Lee; Y S Song
Journal:  Int J Impot Res       Date:  2016-02-18       Impact factor: 2.896

3.  Effect of berberine on the mRNA expression of nitric oxide synthase (NOS) in rat corpus cavernosum.

Authors:  Yan Tan; Zhangyin Ming; Qiang Tang; Zhaojian Jiang; Benrong Hu; Jizhou Xiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

4.  eNOS-uncoupling in age-related erectile dysfunction.

Authors:  J M Johnson; T J Bivalacqua; G A Lagoda; A L Burnett; B Musicki
Journal:  Int J Impot Res       Date:  2011-02-03       Impact factor: 2.896

Review 5.  Emerging and novel therapeutic approaches in the treatment of male erectile dysfunction.

Authors:  Eric Chung; Gerald B Brock
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

Review 6.  Emerging tools for erectile dysfunction: a role for regenerative medicine.

Authors:  Lukman Hakim; Frank Van der Aa; Trinity J Bivalacqua; Petter Hedlund; Maarten Albersen
Journal:  Nat Rev Urol       Date:  2012-07-24       Impact factor: 14.432

7.  Aqueous extract of Lespedeza cuneata improves male menopause by increase of nitric oxide and dihydrotestosterone.

Authors:  Yun-Hee Rhee; Sang-Woo Yoo; Seong Lee; Phil-Sang Chung
Journal:  Food Sci Biotechnol       Date:  2018-07-11       Impact factor: 2.391

Review 8.  Emerging gene and stem cell therapies for the treatment of erectile dysfunction.

Authors:  Ahmed Harraz; Alan W Shindel; Tom F Lue
Journal:  Nat Rev Urol       Date:  2010-02-16       Impact factor: 14.432

Review 9.  Erectile dysfunction: expectations beyond phosphodiesterase type 5 inhibition.

Authors:  A Aversa; M Pili; A Fabbri; E Spera; G Spera
Journal:  J Endocrinol Invest       Date:  2004-02       Impact factor: 4.256

Review 10.  Gas what: NO is not the only answer to sexual function.

Authors:  G Yetik-Anacak; R Sorrentino; A E Linder; N Murat
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.